CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Knight, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Dalhousie University
Halifax, Nova Scotia, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Hospital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Mcgill University
Montreal, Quebec, Canada
- Clinical Research Consultants, Inc.
Hoover, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- Ucla School of Medicine
Los Angeles, California, United States
- Ucsf California
San Francisco, California, United States
- Stanford University Medical Center, Division of Hematology
Stanford, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- Mayo Clinic- Jacksonville
Jacksonville, Florida, United States
- University of Miami
Miami, Florida, United States
- Oncology Hematology Consultants
Sarasota, Florida, United States
- H Lee Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Medical College of Georgia
Augusta, Georgia, United States
- Northwestern University Med Ctr
Chicago, Illinois, United States
- Rush Cancer Institute Section of Hematology
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Indiana Cancer Research Institute
Indianapolis, Indiana, United States
- University of Iowa Hospital Clinic
Iowa City, Iowa, United States
- Ocshner Clinical Foundation
New Orleans, Louisiana, United States
- Johns Hopkins Medicine Department of Oncology
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Washington University School of Medicine- Sherman Cancer Center
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- New York Presbyterian Hospital
New York, New York, United States
- St. Vincent'S Comprehensive Cancer Center
New York, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Mbccop Our Lady of Mercy Cancer Center New York Medical College
The Bronx, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
- Cleveland Clinic Myeloma Program
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2003
- Primary completion
- 1 Nov 2005
- Completion
- 1 Oct 2008
- Last update posted
- 19 Oct 2017
- Registered enrollment
- 353
- Registry id
- NCT00056160
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.